147 related articles for article (PubMed ID: 9699049)
1. Quantitative MRI of hepatocellular carcinoma in cirrhotic and noncirrhotic livers.
Nakayama M; Kamura T; Kimura M; Seki H; Tsukada K; Sakai K
Clin Imaging; 1998; 22(4):280-3. PubMed ID: 9699049
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers.
Winston CB; Schwartz LH; Fong Y; Blumgart LH; Panicek DM
Radiology; 1999 Jan; 210(1):75-9. PubMed ID: 9885590
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.
Di Martino M; Saba L; Bosco S; Rossi M; Miles KA; Di Miscio R; Lombardo CV; Tamponi E; Piga M; Catalano C
Eur Radiol; 2014 Jul; 24(7):1446-54. PubMed ID: 24770466
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
Wang H; Wang XY; Jiang XX; Ye ZX
Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
[TBL] [Abstract][Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
[TBL] [Abstract][Full Text] [Related]
13. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
16. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
[TBL] [Abstract][Full Text] [Related]
17. MR imaging in cirrhosis and hepatocellular carcinoma.
Barr DC; Hussain HK
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J
J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562
[TBL] [Abstract][Full Text] [Related]
19. Regenerating nodules of liver cirrhosis: MR imaging.
Itai Y; Ohnishi S; Ohtomo K; Kokubo T; Yoshida H; Yoshikawa K; Imawari M
Radiology; 1987 Nov; 165(2):419-23. PubMed ID: 2821574
[TBL] [Abstract][Full Text] [Related]
20. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
